← All stocks

Bristol Myers Squibb

BMY Net selling
CIK 0000014272 #77 in the set updated 17 Sep 2026
Bought (120 mo)
$3.93M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$152.30M
$0.00 on a plan · $54.37M straight out of an exercise
Sold at will
$97.93M
62 of 76 sales
Net
−$148.37M
−$94.00M against sales at will

By person

42 insiders · 101 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Caforio Giovanni
Executive Chair of the Board
$36.21M (10)
−$36.21M
432,266
$27.91M
+235.9%
Vessey Rupert
EVP & President, Research
$35.57M (13) scheduled
−$35.57M
48,364
$3.12M
LEUNG SANDRA
EVP, General Counsel
$31.00M (5)
−$31.00M
457,732
$29.56M
+24.4%
Elkins David V
EVP, Chief Financial Officer
$20.73M (7) scheduled
−$20.73M
159,443
$10.30M
Powell Ann
EVP, Chief Human Resources
$6.61M (5)
−$6.61M
27,868
$1.80M
+13.5%
von Autenried Paul
EVP, Chief Information Officer
$5.88M (6)
−$5.88M
63,536
$4.10M
−30.0%
Schmukler Louis S
EVP,Pres.,Glob.Prod. & Supply
$5.09M (5)
−$5.09M
31,956
$2.06M
+45.4%
ANDREOTTI LAMBERTO
Director
$3.72M (4)
−$3.72M
935,571
$60.41M
+412.8%
Samuels Theodore R. II
Director
$1.93M (5)
+$1.93M
35,500
$2.29M
Elicker John E
EVP, Investor Relations
$1.81M (2)
−$1.81M
70,946
$4.58M
+29.0%
BOERNER CHRISTOPHER S.
Chief Executive Officer
$359.71K (3)
$2.04M (1)
−$1.68M
149,764
$9.67M
+5,111%
Caldarella Joseph C
SVP & Controller
$1.02M (2)
−$1.02M
46,297
$2.99M
−16.2%
Paliwal Dinesh C
Director
$749.93K (2)
+$749.93K
22,109
$1.43M
+170.8%
Dubow Adam
SVP,ChiefCompliance&EthicsOff.
$722.32K (5)
−$722.32K
13,777
$889.59K
−6.3%
Santiago Karen Murphy
SVP & Controller
$600.87K (2)
−$600.87K
16,704
$1.08M
+4,045%
BERTOLINI ROBERT J
Director
$491.92K (1)
+$491.92K
11,397
$735.90K
+2,771%
Eid Joseph
SVP,Head Glob. Medical Affairs
$413.60K (2)
−$413.60K
9,485
$612.45K
+173.3%
Massacesi Cristian
EVP,Chief Med Offr,Head of Dev
$403.50K (1)
−$403.50K
18,748
$1.21M
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
$402.27K (3)
+$402.27K
83,513
$5.39M
Lynch Thomas J. Jr.
EVP & Chief Scientific Officer
$335.17K (1)
−$335.17K
22,223
$1.43M
Holzer Phil M
SVP and Controller
$72.68K (2)
−$72.68K
16,862
$1.09M
+68.4%
Plenge Robert M
EVP, Chief Research Officer
$44.75K (1)
−$44.75K
21,528
$1.39M
+194.3%
Short Bartie Wendy
EVP, Corporate Affairs
$16.72K (1) scheduled
−$16.72K
12,684
$819.01K
BONNEY MICHAEL W
Director
$5.18K (1)
+$5.18K
12,501
$807.19K
+201.1%
Hickey Benjamin
President, RayzeBio Org.
$3.70K (1)
−$3.70K
16,672
$1.08M
+1,800%
Bancroft Charles A
EVP, Head of Integration
437,534
$28.25M
+141.7%
Cuss Francis M
EVP & CSO
321,906
$20.79M
+11.1%
Gordon Murdo
EVP, Chief Commercial Officer
49,424
$3.19M
+241.7%
AHMED NADIM
EVP and President, Hematology
40,855
$2.64M
Nielsen Anne
Chief Compliance & Ethics Off
37,974
$2.45M
+31.5%
Mily Elizabeth
EVP, Strategy & BD
34,734
$2.24M
Haller Julia A
Director
34,079
$2.20M
+1,315%
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
30,361
$1.96M
Shanahan Karin
EVP, Chief Supply Chain & Ops
25,888
$1.67M
Blin Emmanuel
SVP, Chief Strategy Officer
20,138
$1.30M
+63.8%
Lenkowsky Adam
EVP, Chief Commercial Officer
19,706
$1.27M
Gallman Cari
EVP, General Counsel
13,649
$881.32K
+6,526%
Hoch Lynelle
President, Cell Therapy Org.
8,210
$530.12K
Poole Ahn Amanda
EVP, Chief People Officer
7,094
$458.06K
Biondi Paul
SVP, Head of Strategy & BD
6,214
$401.24K
Weese Michelle
EVP, Corporate Affairs
3,453
$222.96K
Greenlees Sharon
SVP & Controller
609
$39.32K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Massacesi Cristian
9 Sep 2026
EVP,Chief Med Offr,Head of Dev
Sell
6,249
$64.57
$403.50K
Short Bartie Wendy
1 Sep 2026
EVP, Corporate Affairs
Exercised, kept
1,236
$66.92
$82.71K
Holzer Phil M
25 Aug 2026
SVP and Controller
Sell
500
$67.50
$33.75K
Haller Julia A
15 Jun 2026
Director
Exercised, kept
20,460
$53.76
$1.10M
Elkins David V
1 Apr 2026
EVP, Chief Financial Officer
Sell
4,481
$62.05
$278.05K
Elkins David V
1 Apr 2026
EVP, Chief Financial Officer
Sell
25,519
$61.60
$1.57M
Elkins David V
2 Sep 2025
EVP, Chief Financial Officer
Sell
56,000
$47.33
$2.65M
Short Bartie Wendy
2 Aug 2025
EVP, Corporate Affairs
Sold after exercise
378
$44.23
$16.72K
Hickey Benjamin
9 May 2025
President, RayzeBio Org.
Sell indirect
97
$38.01
$3.70K
Hirawat Samit
25 Apr 2025
EVP,Chief Med.Offr.,Drug Dev.
Buy
4,250
$47.58
$202.22K
BOERNER CHRISTOPHER S.
20 Feb 2025
Chief Executive Officer
Buy
2,000
$55.05
$110.10K
Hirawat Samit
14 Feb 2025
EVP,Chief Med.Offr.,Drug Dev.
Buy
1,823
$54.84
$100.00K
Holzer Phil M
4 Nov 2024
SVP and Controller
Sell
700
$55.62
$38.93K
Hirawat Samit
1 Nov 2024
EVP,Chief Med.Offr.,Drug Dev.
Buy
1,830
$54.68
$100.06K
BOERNER CHRISTOPHER S.
5 Dec 2023
Chief Executive Officer
Buy
2,000
$49.78
$99.56K
BOERNER CHRISTOPHER S.
28 Nov 2023
Chief Executive Officer
Buy
3,071
$48.86
$150.05K
Samuels Theodore R. II
20 Nov 2023
Director
Buy
8,500
$49.81
$423.39K
Powell Ann
24 Aug 2023
EVP, Chief Human Resources
Sell
17,986
$61.25
$1.10M
Plenge Robert M
3 Aug 2023
EVP, Chief Research Officer
Sell
732
$61.14
$44.75K
Vessey Rupert
3 May 2023
EVP & President, Research
Sell
50,385
$67.06
$3.38M
Powell Ann
6 Feb 2023
EVP, Chief Human Resources
Sell
11,183
$74.69
$835.26K
Caforio Giovanni
6 Feb 2023
Board Chair and CEO
Sell
240,000
$74.65
$17.92M
Powell Ann
9 Nov 2022
EVP, Chief Human Resources
Sell
16,250
$80.45
$1.31M
Vessey Rupert
7 Nov 2022
EVP, Research & Early Dev.
Sold after exercise
45,910
$78.88
$3.62M
Caforio Giovanni
20 Sep 2022
Board Chair and CEO
Sell
25,000
$69.71
$1.74M
Caforio Giovanni
15 Sep 2022
Board Chair and CEO
Sell
50,000
$71.84
$3.59M
Powell Ann
14 Sep 2022
EVP, Chief Human Resources
Sell
25,000
$70.75
$1.77M
Elkins David V
13 Sep 2022
EVP, Chief Financial Officer
Sold after exercise
103,951
$71.29
$7.41M
Elkins David V
13 Sep 2022
EVP, Chief Financial Officer
Sold after exercise
30,000
$71.35
$2.14M
Caforio Giovanni
13 Jun 2022
Board Chair and CEO
Sell
30,000
$74.04
$2.22M
LEUNG SANDRA
6 Jun 2022
EVP, General Counsel
Sell
65,000
$74.89
$4.87M
Caforio Giovanni
21 Mar 2022
Board Chair and CEO
Sell
25,000
$71.52
$1.79M
Vessey Rupert
16 Mar 2022
EVP, Research & Early Dev.
Sold after exercise
43,228
$69.23
$2.99M
Vessey Rupert
16 Mar 2022
EVP, Research & Early Dev.
Sold after exercise
31,331
$69.27
$2.17M
BOERNER CHRISTOPHER S.
14 Mar 2022
EVP, Chief Commercial Officer
Sell
29,532
$69.20
$2.04M
Santiago Karen Murphy
14 Mar 2022
SVP & Controller
Sell
6,577
$69.20
$455.10K
Caforio Giovanni
24 Feb 2022
Board Chair and CEO
Sell
30,000
$67.00
$2.01M
Vessey Rupert
16 Dec 2021
EVP, Research & Early Dev.
Sell
13,100
$61.99
$812.07K
Vessey Rupert
16 Dec 2021
EVP, Research & Early Dev.
Sell
6,198
$61.99
$384.18K
von Autenried Paul
24 Nov 2021
EVP, Chief Information Officer
Sell indirect
17,353
$56.92
$987.73K
von Autenried Paul
23 Nov 2021
EVP, Chief Information Officer
Sell indirect
15,418
$57.47
$886.07K
von Autenried Paul
22 Nov 2021
EVP, Chief Information Officer
Sell indirect
18,363
$57.17
$1.05M
Caforio Giovanni
20 Sep 2021
Board Chair and CEO
Sell
25,000
$60.64
$1.52M
Elkins David V
12 Aug 2021
EVP, Chief Financial Officer
Sold after exercise
59,691
$67.00
$4.00M
Elkins David V
12 Aug 2021
EVP, Chief Financial Officer
Sold after exercise
40,000
$66.88
$2.68M
Powell Ann
3 Aug 2021
EVP, Chief Human Resources
Sell
23,280
$68.57
$1.60M
Caforio Giovanni
2 Aug 2021
Chairman and CEO
Sell
20,000
$68.58
$1.37M
von Autenried Paul
30 Jul 2021
EVP, Chief Information Officer
Sell
25,000
$68.06
$1.70M
Vessey Rupert
30 Jul 2021
EVP, Research & Early Dev.
Sold after exercise
140,653
$68.08
$9.58M
Vessey Rupert
30 Jul 2021
EVP, Research & Early Dev.
Sold after exercise
17,740
$68.01
$1.21M
LEUNG SANDRA
30 Jul 2021
EVP, General Counsel
Sell
29,390
$68.04
$2.00M
Dubow Adam
30 Jul 2021
SVP,ChiefCompliance&EthicsOff.
Sell
2,466
$67.90
$167.44K
Schmukler Louis S
10 May 2021
EVP,Pres.,Glob.Prod. & Supply
Sell
15,000
$65.25
$978.75K
Eid Joseph
10 May 2021
SVP,Head Glob. Medical Affairs
Sell
1,118
$65.00
$72.67K
Vessey Rupert
5 May 2021
EVP, Research & Early Dev.
Sell
30,546
$64.29
$1.96M
Dubow Adam
5 May 2021
SVP,ChiefCompliance&EthicsOff.
Sell
3,119
$64.21
$200.27K
Caforio Giovanni
22 Mar 2021
Chairman and CEO
Sell
25,000
$62.20
$1.56M
von Autenried Paul
25 Nov 2020
EVP, Chief Information Officer
Sell
3
$63.50
$190.50
von Autenried Paul
24 Nov 2020
EVP, Chief Information Officer
Sell
20,000
$62.75
$1.26M
Dubow Adam
24 Nov 2020
SVP,ChiefCompliance&EthicsOff.
Sell
900
$63.39
$57.05K
Vessey Rupert
23 Nov 2020
EVP, Research & Early Dev.
Sell
13,421
$61.34
$823.24K
Vessey Rupert
19 Nov 2020
EVP, Research & Early Dev.
Sold after exercise
47,012
$61.31
$2.88M
Vessey Rupert
19 Nov 2020
EVP, Research & Early Dev.
Sold after exercise
10,579
$61.25
$647.96K
Caforio Giovanni
31 Aug 2020
Chairman and CEO
Sell
39,840
$62.70
$2.50M
Eid Joseph
17 Aug 2020
SVP,Head Glob. Medical Affairs
Sell
5,327
$64.00
$340.93K
LEUNG SANDRA
13 Aug 2020
EVP, General Counsel
Sell
141,420
$63.24
$8.94M
Paliwal Dinesh C
15 Jun 2020
Director
Buy
9,174
$54.50
$499.98K
Dubow Adam
22 May 2020
SVP,ChiefCompliance&EthicsOff.
Sell
3,200
$61.01
$195.23K
Schmukler Louis S
19 May 2020
EVP,Pres.,Glob.Prod. & Supply
Sell
25,000
$62.68
$1.57M
Elicker John E
4 Mar 2020
EVP, Investor Relations
Sell
15,805
$61.01
$964.26K
Vessey Rupert
2 Mar 2020
Pres., Research & Early Dev.
Sold after exercise
84,308
$60.59
$5.11M
Dubow Adam
5 Dec 2019
Chief Compliance & Ethics Offi
Sell
1,740
$58.81
$102.33K
BONNEY MICHAEL W
4 Dec 2019
Director
Buy
88
$58.90
$5.18K
Elicker John E
5 Nov 2019
SVP, Public Affairs & IR
Sell
15,000
$56.66
$849.90K
Schmukler Louis S
5 Nov 2019
Pres., Global Mfg. & Supply
Sell
25,000
$56.56
$1.41M
BERTOLINI ROBERT J
31 Jul 2019
Director
Buy
11,000
$44.72
$491.92K
Samuels Theodore R. II
16 May 2019
Director
Buy
5,000
$47.29
$236.44K
Santiago Karen Murphy
16 May 2019
Controller
Sell
3,065
$47.56
$145.77K
Bancroft Charles A
28 Feb 2019
EVP & Chief Financial Officer
Exercised, kept
52,884
$17.51
$926.00K
LEUNG SANDRA
28 Feb 2019
EVP, General Counsel
Exercised, kept
169,893
$17.51
$2.97M
Paliwal Dinesh C
30 Apr 2018
Director
Buy
4,770
$52.40
$249.95K
Bancroft Charles A
23 Feb 2018
EVP & Chief Financial Officer
Exercised, kept
37,460
$22.14
$829.36K
Samuels Theodore R. II
15 Dec 2017
Director
Buy
4,000
$62.30
$249.19K
Lynch Thomas J. Jr.
12 Dec 2017
EVP & Chief Scientific Officer
Sell
5,300
$63.24
$335.17K
LEUNG SANDRA
4 Dec 2017
EVP, General Counsel
Sold after exercise
156,582
$63.37
$9.92M
Caldarella Joseph C
6 Sep 2017
SVP & Controller
Sell
9,340
$60.00
$560.40K
Samuels Theodore R. II
2 Aug 2017
Director
Buy
6,000
$55.94
$335.62K
ANDREOTTI LAMBERTO
7 Apr 2017
Director
Sell
17,000
$53.22
$904.79K
ANDREOTTI LAMBERTO
6 Apr 2017
Director
Sell
17,000
$53.29
$905.96K
ANDREOTTI LAMBERTO
28 Mar 2017
Director
Sell
17,000
$56.20
$955.37K
ANDREOTTI LAMBERTO
27 Mar 2017
Director
Sell
17,000
$56.14
$954.45K
Schmukler Louis S
17 Mar 2017
Pres., Global Mfg. & Supply
Sell
5,000
$56.49
$282.47K
Caldarella Joseph C
15 Mar 2017
SVP & Controller
Sell
8,096
$57.29
$463.78K
Schmukler Louis S
14 Mar 2017
Pres., Global Mfg. & Supply
Sell
15,000
$56.75
$851.22K
LEUNG SANDRA
6 Mar 2017
EVP, General Counsel
Sell
92,405
$57.02
$5.27M
LEUNG SANDRA
3 Mar 2017
EVP, General Counsel
Exercised, kept
116,100
$27.01
$3.14M
Bancroft Charles A
28 Feb 2017
EVP & Chief Financial Officer
Exercised, kept
22,598
$27.01
$610.37K
Samuels Theodore R. II
27 Feb 2017
Director
Buy
12,000
$56.77
$681.24K
ANDREOTTI LAMBERTO
30 Jan 2017
Director
Exercised, kept
100,000
$27.01
$2.70M
ANDREOTTI LAMBERTO
1 Nov 2016
Director
Exercised, kept
305,909
$22.14
$6.77M
ANDREOTTI LAMBERTO
11 Oct 2016
Director
Exercised, kept
368,706
$17.51
$6.46M

What was left out

Form 4 filings counted 806
Amendments (4/A) skipped 12
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 62
Transactions with no price 0
Shares from compensation/vesting 11,985,719
Sales filed before the plan box existed 52
History held since 7 Sep 2016